第 33 屆 TRI-CON 將邀集高級投資者、製藥公司高管、企業家、研究思想領袖和創新者。您將可在親密互動單元和投資者及合作夥伴交流，並透過產業主導的小組討論，深入了解診斷、精準醫療和人工智慧領域的融資、業務拓展和創新策略，同時也可在活躍的爐邊談話中聽取 KOL 的坦誠見解和商業建議。TRI-CON 擁有超過 30 年的經驗，是主要利害關係人加深有意義的人脈、獲取寶貴策略見解並推動創新與合作的首選平台。讓我們2026年舊金山再見！
2025 Featured Speakers
Mara Aspinall
Partner
Illumina Ventures
Peter Foley
CEO
LetsGetChecked
Lisa Alderson
CEO
Adela
Gabriele Allegri
VP, Global Commercial Precision Medicine
Johnson & Johnson
Alex Aravanis
CEO
Moonwalk Biosciences
Omar Perez
Head of Medical Diagnostics
AstraZeneca
Jenny Rooke
Managing Director
Genoa Ventures
Ajit Singh
Partner
Artiman Ventures
Susan Tousi
CEO
DELFI Diagnostics
Steffan Ho
VP, Translational Oncology
Pfizer
Lourdes Barrera
Executive Director, Precision Medicine
Merck
Christopher Conn
Director, Diagnostics Strategy
Amgen
Andrea L. Stevens
Senior Director
Precision Medicine Access, Johnson & Johnson
Ezra Cohen
CMO, Oncology
Tempus Labs
Hoi-Ying Elsie Yu
Laboratory Director, Point-of-Care Testing
Geisinger Health
Jai Pandey
Head, Global Device Regulatory IVD/CDx
Sanofi
Edward Abrahams
Former President
Personalized Medicine Coalition
Kyle Farh
VP, Artificial Intelligence Lab
Illumina
Howard Scher
Head, Biomarker Development Program
Memorial Sloan Kettering Cancer Center
Shawn Carlson
Vice President, Head of Market Access
Roche Diagnostics
Friends of TRI-CON,
歷屆TRI-CON精彩回顧
